This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Aaron's(AAN) downgraded at Canaccord from buy to hold, Canaccord Genuity said. $30 price target. Rent-to-own industry remains under pressure.
AbbVie(ABBV) rated new neutral at Credit Suisse. $37 price target. Cross currents imply minimal stock movement from current price.
Akamai Tech(AKAM) downgraded at Jefferies to hold from buy, Jefferies said. $40 price target. Reinvestments tough on short- term outlook.
Compass Minerals International(CMP) upgraded to buy at TheStreet Ratings.
Conceptus(CPTS) upgraded to buy at TheStreet Ratings.
Con-Way(CNW) upgraded at Citigroup to buy from neutral, Citigroup said. $39 price target. Incremental margin and cost analysis suggests upside to 1H13 EPS.
DeVry(DV) upgraded at JP Morgan from underweight to neutral, JP Morgan said. Company is seeing higher enrollment rates.
Fortune Brands Home & Security(FBHS) upgraded at KeyBanc to buy from hold, KeyBanc said. $38 price target. Company outgrows peers on the basis of its attractive market positions.
Google(GOOG - Get Report) downgraded at Pivotal from buy to hold, Pivotal Research said. Valuation call, based on an $820 price target.
Google rated new neutral at Sterne Agee. Company mays struggle to monetize its mobile business.
Johnson & Johnson(JNJ - Get Report) downgraded at Credit Suisse from neutral to underperform, Credit Suisse said. Valuation call, based on a $73 price target.
Life Time Fitness(LTM) upgraded at Stifel from hold to buy, Stifel Nicolaus said. $50 price target. Stock appears oversold at current levels.
Molycorp(MCP) upgraded at JP Morgan from underweight to neutral, JP Morgan said. $6 price target. Capital raise removes near-term risks.
Owens Corning(OC) downgraded at KeyBanc to hold from buy, KeyBanc said. High growth expectations and past margin volatility.
PACCAR(PCAR) downgraded at UBS to neutral from buy, UBS said. $48 price target. Valuation call.
Pfizer(PFE - Get Report) downgraded at Credit Suisse from Outperform to neutral, Credit Suisse said. New analyst has a $29 price target.
Reliance Steel(RS) upgraded at Dahlman from hold to buy, Dahlman Rose said. $89 price target. MUSA deal should add to earnings.
Stryker(SYK) downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. Valuation call, based on a $67 price target.